URMC / Research / Clinical Trials / Study Details

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)

Research Question:
Does the drug UTR1147A help patients with ulcerative colitis?

Basic Study Information

Purpose:
This study is designed to evaluate the efficacy, safety, and pharmacokinetics of UTTR1147A compared with vedolizumab and with placebo in the treatment of participants with moderate to severe UC. This study will consist of two parts, Part A and Part B. Part A will test the induction of clinical remission and Part B will test the durability of clinical remission.

Location: University of Rochester Medical Center

Lead Researcher (Principal Investigator)

Lead Researcher: Lawrence Saubermann

Study Contact Information

Study Coordinator: Reference Study ID: GA39925 www.roche.com/about_roche/roche_worldwide.htm
Phone: (888) 662-6728
Email: global-roche-genentech-trials@gene.com

Additional Study Details

Contact This Study

First Name *

This field is required

Middle Name

Last Name *

This field is required

Phone Number

I agree to be contacted by The University of Rochester Medical Center regarding participation in this study. *

You must agree to be contacted to continue.

Please call me during the day.

Please call me during the evening.

Message

Return to Search

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Wilmot Research